Radical resection for carcinoma of the ampulla of Vater

J. R. Monson, J. H. Donohue, G. P. McEntee, D. C. McIlrath, J. A. van Heerden, R. G. Shorter, D. M. Nagorney and D. M. Ilstrup
Department of Surgery, Mayo Clinic, Rochester, MN 55905.

One hundred four consecutive patients who underwent radical resection for ampullary cancer between 1965 and 1989 were retrospectively reviewed. Frequent clinical findings included jaundice (67%), significant (greater than 10%) weight loss (42%), and anemia (27%). Eighty-seven patients (84%) underwent a subtotal pancreatectomy, and 17 patients (16%) underwent a total pancreatectomy. The postoperative mortality was 5.7% (six patients), and reoperation for postoperative complications was required in six patients. The 5- and 10-year survival rates were 34% and 25%, respectively. Eight patients died of tumor recurrence more than 5 years after resection. Patient survival was significantly impaired by microscopic lymphatic invasion, regional nodal metastasis, tumor grade, and the epithelium of origin. In a multivariate analysis, only microscopic lymphatic invasion significantly reduced patient survival. Radical resection for ampullary cancer can be performed with a low morbidity and mortality and should remain the procedure of choice for ampullary carcinoma.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Survival After Resection of Ampullary Carcinoma: A National Population-Based Study
O'Connell et al.
Ann. Surg. Oncol. 2008;15:1820-1827.
ABSTRACT | FULL TEXT  

Predictors for Patterns of Failure after Pancreaticoduodenectomy in Ampullary Cancer
Hsu et al.
Ann. Surg. Oncol. 2007;14:50-60.
ABSTRACT | FULL TEXT  

Limitations of Ampullectomy in the Treatment of Nonfamilial Ampullary Neoplasms
Roggin et al.
Ann. Surg. Oncol. 2005;12:971-980.
ABSTRACT | FULL TEXT  

Pancreaticoduodenectomy Is Curative in the Majority of Patients With Node-Negative Ampullary Cancer
Brown et al.
Arch Surg 2005;140:529-533.
ABSTRACT | FULL TEXT  

Patterns and Predictors of Failure after Curative Resections of Carcinoma of the Ampulla of Vater
Todoroki et al.
Ann. Surg. Oncol. 2003;10:1176-1183.
ABSTRACT | FULL TEXT  

Improved Survival for Adenocarcinoma of the Ampulla of Vater: Fifty-five Consecutive Resections
Duffy et al.
Arch Surg 2003;138:941-950.
ABSTRACT | FULL TEXT  

Adjuvant Chemoradiotherapy for "Unfavorable" Carcinoma of the Ampulla of Vater: Preliminary Report
Mehta et al.
Arch Surg 2001;136:65-69.
ABSTRACT | FULL TEXT  

Biliary Tract Cancers
de Groen et al.
NEJM 1999;341:1368-1378.
FULL TEXT